New Insights into Cardiac and Vascular Natriuretic Peptides: Findings from Young Adults Born with Very Low Birth Weight

Clinical Chemistry
Timothy C R PrickettEric A Espiner

Abstract

In community studies, plasma B-type natriuretic peptide (BNP) is positively associated with cardiovascular disorders. Those born with very low birth weight (VLBW) have increased risk of metabolic and vascular disorders in later life, but plasma concentrations of natriuretic peptides have not been studied. The objectives here were to evaluate BNP and C-type natriuretic peptide (CNP)-a putative marker of vascular risk-in young adults born with VLBW. In all, 220 VLBW cases and 97 matched controls were studied 28 years after birth during a 2-day period at 1 research center. Aminoterminal (NT) products (NTproBNP, NTproCNP) and a range of conventional vascular risk factors including echocardiographic indices were measured along with genetic polymorphisms known to increase plasma NTproBNP. VLBW individuals were smaller, had smaller hearts, reduced stroke volume and endothelial function, and higher systolic blood pressure and arterial elastance. Of the many humoral vascular and metabolic risk factors measured, including NTproBNP, only plasma NTproCNP (higher in VLBW individuals) differed significantly. Across all individuals, associations of NTproCNP with each of 7 conventional risk factors, as well as with arterial elastance, were pos...Continue Reading

References

Aug 21, 2001·Biochemical and Biophysical Research Communications·T C PrickettA M Richards
Feb 13, 2004·The New England Journal of Medicine·Thomas J WangRamachandran S Vasan
Dec 13, 2005·The Journal of Clinical Investigation·Kush M ParmarGuillermo García-Cardeña
Feb 18, 2011·International Journal of Epidemiology·Kari R RisnesMichael B Bracken
Aug 6, 2011·Peptides·Donald F SellittiMaria C Mendonça
Sep 13, 2011·Nature·UNKNOWN International Consortium for Blood Pressure Genome-Wide Association StudiesToby Johnson
May 16, 2012·Frontiers in Physiology·Paul D Chantler, Edward G Lakatta
Jun 5, 2013·Diabetes·Mariana LazoElizabeth Selvin
Apr 8, 2015·BJOG : an International Journal of Obstetrics and Gynaecology·E A EspinerL M McCowan
Apr 9, 2015·The New England Journal of Medicine·Christopher P NelsonUNKNOWN CARDIoGRAM+C4D Consortium
May 23, 2015·Journal of the American Heart Association·Christopher R deFilippi, Stephen L Seliger
Sep 8, 2016·The Lancet. Diabetes & Endocrinology· Natriuretic Peptides Studies CollaborationEmanuele Di Angelantonio
Jan 8, 2017·Clinical Chemistry·Timothy C R PrickettA Mark Richards
Jul 29, 2017·The American Journal of Cardiology·Deepak K GuptaThomas J Wang

❮ Previous
Next ❯

Citations

Jan 8, 2017·Clinical Chemistry·Timothy C R PrickettA Mark Richards
May 21, 2020·Diabetes Therapy : Research, Treatment and Education of Diabetes and Related Disorders·Alexander E Berezin, Alexander A Berezin
Jul 3, 2021·International Journal of Environmental Research and Public Health·Abigail Muñoz-RodríguezCitlalli Osorio-Yáñez
Mar 8, 2019·Hormone Research in Pædiatrics·Eric EspinerRobert Olney

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Cardiovascular Risk Assessment

Sensitive and accurate biomarkers used in cardiovascular risk prediction can potentially be used to manage the risk of cardiovascular disease. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here. Discover the latest research on Biomarkers for Cardiovascular Risk Assessment here.